Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Quality metrics (QMs) are fundamental tools used to measure, monitor, and evaluate clinical practice across different healthcare settings. The implementation of continuous quality improvement programs (CQIPs) has been reported to enhance these QMs in patients undergoing continuous renal replacement therapy (CRRT). The aim of this study was to compare the degree of goal achievement in CRRT QMs before and after the sequential implementation of a CQIP in two university hospitals.
This ambispective study was divided into three periods (Figure 1): Period 1 (retrospective, 2016–2019), before CQIP implementation in Hospital 1; Period 2 (prospective, 2020–2023), after CQIP implementation in Hospital 1; and Period 3 (prospective, 2024–2025), following the initiation of a CRRT program in Hospital 2 with the CQIP. The CQIP included the use of regional citrate anticoagulation (RCA) and a structured continuing education program for nursing and medical staff responsible for CRRT. Clinical and technical data were collected, QMs were calculated, and comparisons were made across the periods.
A total of 209, 412, and 377 CRRT sessions were performed in 59, 93, and 89 patients during Periods 1, 2, and 3, respectively (Table 1). RCA was used in 45.6% and 77% of the sessions in Periods 2 and 3, respectively. The median filter lifespan increased from 36.5 hours in Period 1 to 64 hours in Period 2 and 81 hours in Period 3. The proportion of filters with a lifespan >60 hours rose from 23% in Period 1 to 54.5% in Period 2 and 71% in the last period. The proportion of sessions with a delivered-to-prescribed dose ratio >80% increased from 84% to 88% and up to 94%, respectively. Achievement of the ultrafiltration goal (>80%) was 66%, 63%, and 76% across the three periods. The percentage of sessions with downtime <10% was 65.5%, 70%, and increased to 90.6% in the last period. The rate of therapy-related adverse events was 8% in the first period, increased to 32% in the second, and decreased again to 8% in the third period. Overall, the percentage of goals achieved per period showed a marked improvement in the third period compared with the first and second.
The implementation of a CQIP in CRRT, as well as its integration from the initiation of a new program, was associated with substantial improvements in filter lifespan and compliance with key QMs. These findings suggest a more efficient use of resources and potential optimization of care for critically ill patients undergoing CRRT.
This abstract has been accepted for presentation at the American Society of Nephrology (ASN) Kidney Week 2025, to be held in November 2025 in Houston, Texas.
